September 27, 2016 /
Click here to receive MS news via e-mail
“Seven MS drugs that were previously excluded–as was
Biogen’s Plegridy–or otherwise restricted will be freely available. These include
Biogen’s Tecfidera, Novartis’ Gilenya and Sanofi’s Aubagio, three of the new
generation of oral treatments”
Biogen’s Plegridy–or otherwise restricted will be freely available. These include
Biogen’s Tecfidera, Novartis’ Gilenya and Sanofi’s Aubagio, three of the new
generation of oral treatments”
READ Article by clicking here
MS Views and News
Providing educational information, resources and services for those affected by MS
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
